TELA Bio to Announce Second Quarter 2024 Financial Results
TELA Bio (NASDAQ: TELA), a commercial-stage medical technology company specializing in soft-tissue reconstruction solutions, has announced its plan to report second quarter 2024 financial results on Monday, August 12, 2024. The company will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the financial results and provide a corporate update.
Investors interested in participating in the conference call are required to register online at least a day in advance or a minimum of 15 minutes before the call starts. A live webcast and replay of the event will be accessible through the Events & Presentations page in the investor section of TELA Bio's website.
TELA Bio (NASDAQ: TELA), un'azienda di tecnologia medica in fase commerciale specializzata in soluzioni per la ricostruzione dei tessuti molli, ha annunciato il suo piano di riportare i risultati finanziari del secondo trimestre 2024 il lunedì 12 agosto 2024. L'azienda ospiterà una conference call e un webcast alle 16:30 ET lo stesso giorno per discutere i risultati finanziari e fornire un aggiornamento aziendale.
Gli investitori interessati a partecipare alla conference call devono registrarsi online almeno un giorno prima o al massimo 15 minuti prima dell'inizio della chiamata. Un webcast dal vivo e la replica dell'evento saranno accessibili attraverso la pagina Eventi & Presentazioni nella sezione investitori del sito web di TELA Bio.
TELA Bio (NASDAQ: TELA), una empresa de tecnología médica en etapa comercial especializada en soluciones para la reconstrucción de tejidos blandos, ha anunciado su plan de informar sobre los resultados financieros del segundo trimestre de 2024 el lunes 12 de agosto de 2024. La empresa llevará a cabo una llamada de conferencia y un webcast a las 4:30 p.m. ET el mismo día para discutir los resultados financieros y proporcionar una actualización corporativa.
Los inversores interesados en participar en la llamada de conferencia deben registrarse en línea al menos un día antes o como mínimo 15 minutos antes de que comience la llamada. Un webcast en vivo y la repetición del evento estarán disponibles a través de la página de Eventos & Presentaciones en la sección para inversores del sitio web de TELA Bio.
TELA Bio (NASDAQ: TELA)는 연부조직 재건 솔루션을 전문으로 하는 상업적 단계의 의료 기술 회사로, 2024년 2분기 재무 결과를 2024년 8월 12일 월요일에 보고할 계획을 발표했습니다. 회사는 같은 날 오후 4:30 ET에 재무 결과를 논의하고 기업 업데이트를 제공하기 위해 컨퍼런스 콜 및 웹캐스트를 개최할 것입니다.
컨퍼런스 콜에 참여하고자 하는 투자자는 최소 하루 전에 온라인 등록을 하거나 전화를 시작하기 최소 15분 전에 등록해야 합니다. 생중계 웹캐스트와 이벤트 재생은 TELA Bio 웹사이트의 투자자 섹션에 있는 이벤트 및 프레젠테이션 페이지를 통해 확인할 수 있습니다.
TELA Bio (NASDAQ: TELA), une entreprise de technologie médicale en phase commerciale spécialisée dans les solutions de reconstruction des tissus mous, a annoncé son intention de publier les résultats financiers du deuxième trimestre 2024 le lundi 12 août 2024. L'entreprise organisera une conférence téléphonique et un webcast à 16h30 ET le même jour pour discuter des résultats financiers et fournir une mise à jour de l'entreprise.
Les investisseurs souhaitant participer à la conférence téléphonique sont tenus de s'inscrire en ligne au moins un jour à l'avance ou au moins 15 minutes avant le début de l'appel. Un webcast en direct et une rediffusion de l'événement seront accessibles via la page Événements & Présentations dans la section des investisseurs du site Web de TELA Bio.
TELA Bio (NASDAQ: TELA), ein kommerziell tätiges Medizintechnikunternehmen, das sich auf Lösungen zur Rekonstruktion von Weichgewebe spezialisiert hat, hat seinen Plan bekannt gegeben, die Finanzergebnisse des zweiten Quartals 2024 am Montag, den 12. August 2024 zu melden. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und ein Webcast abhalten, um die Finanzergebnisse zu besprechen und ein Unternehmensupdate zu geben.
Investoren, die an der Telefonkonferenz teilnehmen möchten, müssen sich mindestens einen Tag im Voraus oder mindestens 15 Minuten vor Beginn der Konferenz online registrieren. Ein Live-Webcast und eine Wiederholung der Veranstaltung werden über die Seite für Veranstaltungen & Präsentationen im Investorenbereich der TELA Bio-Website zugänglich sein.
- None.
- None.
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report second quarter 2024 financial results on Monday, August 12, 2024. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Second Quarter Earnings Conference Call and Webcast Details
Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed via the Events & Presentations page of the investor section of TELA's website.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Caution Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA Bio's management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated by such forward-looking statements. These risks and uncertainties are described more fully in the "Risk Factors" section and elsewhere in our filings with the Securities and Exchange Commission and available at www.sec.gov, including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA Bio assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.
Investor Contact
Greg Chodaczek
347-620-7010
ir@telabio.com
FAQ
When will TELA Bio (TELA) report its Q2 2024 financial results?
What time is TELA Bio's Q2 2024 earnings conference call scheduled for?
How can investors participate in TELA Bio's Q2 2024 earnings call?
Where can I access the webcast of TELA Bio's Q2 2024 earnings call?
